Observational studyPloS one2019

Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study.

Min Jun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.